COPD夜间呼吸力学恶化及支气管扩张剂治疗的影响
结果显示安慰剂组夜间呼吸力学显著恶化,支气管扩张剂虽未改善晨间谷值IC,但持续改善夜间动态呼吸力学和吸气神经驱动。
要点
- COPD患者夜间气道阻力、肺过度充气和吸气神经驱动显著恶化
核心结论
- 安慰剂期间COPD患者夜间呼吸力学显著恶化,晚间支气管扩张剂治疗虽未改变晨间谷值IC,但与安慰剂相比持续改善夜间动态呼吸力学和吸气神经驱动。
研究设计与样本
- 比较晚间双长效支气管扩张剂(阿地溴铵/福莫特罗富马酸二水合物400/12 μg)与安慰剂,主要终点为给药后12小时晨间谷值IC。
主要发现
- 安慰剂期间,总气道阻力、肺过度充气、吸气神经驱动及潮式食管和跨膈压摆幅较基线晚间值均显著增加。
临床怎么用
- COPD患者夜间呼吸力学和吸气神经驱动明显恶化,晚间支气管扩张剂可改善夜间动态呼吸力学,但晨间谷值IC未变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: COPD is associated with nighttime respiratory symptoms, poor sleep quality, and increased risk of nocturnal death. Overnight deterioration of inspiratory capacity (IC) and FEV1 have been documented previously. However, the precise nature of this deterioration and mechanisms by which evening bronchodilation may mitigate this occurrence have not been studied. RESEARCH QUESTION: What is the effect of evening dosing of dual, long-acting bronchodilation on detailed nocturnal respiratory mechanics and inspiratory neural drive (IND)? STUDY DESIGN AND METHODS: A double-blind, randomized, placebo-controlled crossover study assessed the effects of evening long-acting bronchodilation (aclidinium bromide/formoterol fumarate dihydrate: 400/12 μg) or placebo on morning trough IC (12 h after the dose; primary outcome) and serial overnight measurements of spirometry, dynamic respiratory mechanics, and IND (secondary outcomes). Twenty participants with COPD (moderate/severe airway obstruction and lung hyperinflation) underwent serial measurements of IC, spirometry, breathing pattern, esophageal and transdiaphragmatic pressures, and diaphragm electromyography (diaphragmatic electromyography as a percentage of maximum; IND) at 6 time points from 0 to 12 h after the dose and compared with sleeping IND. RESULTS: Compared with placebo, evening bronchodilation was not associated with increased morning trough IC 12 h after the dose (P = .48); however, nadir IC (lowest IC, independent of time), peak IC, area under the curve for 12 h after the dose, and IC for 10 h after the dose were improved (P < .05). During placebo, total airways resistance, lung hyperinflation, IND, and tidal esophageal and transdiaphragmatic pressure swings all increased significantly overnight compared with baseline evening values; however, each of these parameters improved with bronchodilator treatment (P < .05) with no change in ventilation or breathing pattern. INTERPRETATION: Respiratory mechanics significantly deteriorated at night during placebo. Although the morning trough IC was unchanged, evening bronchodilator treatment was associated consistently with sustained overnight improvements in dynamic respiratory mechanics and inspiratory neural drive compared with placebo CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT02429765.
引用
- Domnik NJ, James MD, Scheeren RE, et al. Deterioration of Nighttime Respiratory Mechanics in COPD: Impact of Bronchodilator Therapy. Chest. 2020. PMID: 32603714. doi:10.1016/j.chest.2020.06.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。